BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1719296)

  • 1. Amrinone reduces pulmonary vascular resistance elevated by U46619 in isolated perfused lungs.
    Clarke WR; Morray JP; Powers K; Soltow LO
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):85-94. PubMed ID: 1719296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of propofol on normal and increased pulmonary vascular resistance in isolated perfused rabbit lung.
    Uezono S; Clarke WR
    Anesth Analg; 1995 Mar; 80(3):577-82. PubMed ID: 7864429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP.
    Wilson PS; Thompson WJ; Moore TM; Khimenko PL; Taylor AE
    J Surg Res; 1997 Jun; 70(1):75-83. PubMed ID: 9228932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin effects in isolated, perfused lamb lungs: role of cyclooxygenase inhibition and vasomotor tone.
    Toga H; Usha Raj J; Hillyard R; Ku B; Anderson J
    Am J Physiol; 1991 Aug; 261(2 Pt 2):H443-50. PubMed ID: 1908640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amrinone and the pulmonary vascular pressure-flow relationship in conscious control dogs and following left lung autotransplantation.
    Nyhan DP; Pribble CG; Peterson WP; Nishiwaki K; Trempy GA; Desai PM; Rock P; Murray PA
    Anesthesiology; 1993 Jun; 78(6):1166-74. PubMed ID: 8512111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of responses to serotonin in the pulmonary vascular bed of the cat.
    McMahon TJ; Hood JS; Nossaman BD; Kadowitz PJ
    J Appl Physiol (1985); 1993 Jul; 75(1):93-102. PubMed ID: 8104177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic vasoconstriction modulates the responses of pulmonary vasculature and airway to vasoconstrictors in anesthetized rats.
    Wang M; Shibamoto T; Kuda Y; Tanida M; Kurata Y
    Exp Lung Res; 2015; 41(6):324-34. PubMed ID: 26151368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of catecholamines on pulmonary circulation at elevated vascular tone.
    Barman SA
    J Appl Physiol (1985); 1995 Apr; 78(4):1452-8. PubMed ID: 7615455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of vasoactive intestinal contractor on the feline pulmonary vascular bed.
    Kadowitz PJ; Kvamme P; Nossaman BD; Ibrahim IN; Minkes RK
    Eur J Pharmacol; 1991 Feb; 194(1):127-30. PubMed ID: 2060589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative responses to endothelin-2 and sarafotoxin 6b in the pulmonary vascular bed of the cat.
    Minkes RK; Nossaman BD; Kvamme P; Kadowitz PJ
    Can J Physiol Pharmacol; 1991 Feb; 69(2):211-4. PubMed ID: 2054734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled nitric oxide in isolated pig lungs.
    Cremona G; Higenbottam T; Takao M; Hall L; Bower EA
    J Appl Physiol (1985); 1995 Jan; 78(1):59-63. PubMed ID: 7713844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
    Seale JP; Nourshargh S; Hellewell PG; Williams TJ
    Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide does not alter the longitudinal distribution of pulmonary vascular resistance.
    Lindeborg DM; Kavanagh BP; Van Meurs K; Pearl RG
    J Appl Physiol (1985); 1995 Jan; 78(1):341-8. PubMed ID: 7713835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of acetylcholine and endothelin-1 in the modulation of pulmonary arterial pressure.
    Schmeck J; Konrad C; Schöffel S; Wendel-Wellner M; Gluth H; Koch T; Krafft P
    Crit Care Med; 2000 Dec; 28(12):3869-75. PubMed ID: 11153628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications.
    Robinson BW; Gelband H; Mas MS
    J Am Coll Cardiol; 1993 May; 21(6):1461-5. PubMed ID: 8473656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary vascular and airway responses to systemic vasoconstrictors in anesthetized BALB/c mice.
    Wang M; Shibamoto T; Shinomiya S; Yamamoto Y; Kurata Y; Kuda Y; Tanida M; Toga H
    J Cardiovasc Pharmacol; 2015 Apr; 65(4):325-34. PubMed ID: 25853950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of thromboxane and prostacyclin effects on pulmonary vascular resistance.
    Barnard JW; Ward RA; Adkins WK; Taylor AE
    J Appl Physiol (1985); 1992 May; 72(5):1845-53. PubMed ID: 1534797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of nifedipine, verapamil and diltiazem on pulmonary vascular resistance and vasoconstrictors in cats.
    Erdemli O; Hao Q; Cai B; Lippton HL; Hyman A
    Arch Int Pharmacodyn Ther; 1994; 328(2):165-79. PubMed ID: 7535994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin aerosol and inhaled nitric oxide fail to reverse pulmonary vasoconstriction induced by thromboxane analogue in dogs.
    Welte M; Zwissler B; Habler O; Kleen M; Messmer K
    Acta Physiol Scand; 1995 Jul; 154(3):395-405. PubMed ID: 7572237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5,6-Epoxyeicosatrienoic acid reduces increases in pulmonary vascular resistance in the dog.
    Stephenson AH; Sprague RS; Lonigro AJ
    Am J Physiol; 1998 Jul; 275(1):H100-9. PubMed ID: 9688901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.